CodeMap® Compliance Briefing: 4/17/09
Comparative effectiveness (CE) has become a popular buzzword in Washington and may play an important part in healthcare reform efforts. CE studies are designed to compare multiple tests or treatments to determine which is the most effective in terms of clinical outcomes. Due to regulatory constraints, costs may not be considered in a given study. However, tests or procedures that are both cost effective, as well as clinically effective will be the most likely to be included in future treatment guidelines and coverage policy. Today, we will define various aspects of CE studies, the dramatically increased funding now available for such investigations, and the impact these studies may have on Medicare coverage and reim....
Sorry, the full document you are trying to access requires an active subscription.
Please login to the left.